{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Escitalopram+%28Oral+antidepressant%29&page=2", "query": { "intervention": "Escitalopram (Oral antidepressant)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 43, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Escitalopram+%28Oral+antidepressant%29&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Escitalopram+%28Oral+antidepressant%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T00:43:47.271Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01324700", "title": "Antidepressant Treatment at an Inner City Asthma Clinic", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Depression", "Asthma" ], "interventions": [ { "name": "High severity group: Escitalopram", "type": "DRUG" }, { "name": "High severity group: Placebo", "type": "DRUG" }, { "name": "Low severity group: Escitalopram", "type": "DRUG" }, { "name": "Low severity group: Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 139, "start_date": "2010-07", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2018-05-22", "last_synced_at": "2026-10-09T00:43:47.271Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01324700" }, { "nct_id": "NCT00456430", "title": "Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant Response", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Depression" ], "interventions": [ { "name": "Escitalopram", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 80, "start_date": "2003-07", "completion_date": "2007-08", "has_results": false, "last_update_posted_date": "2011-11-15", "last_synced_at": "2026-10-09T00:43:47.271Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00456430" }, { "nct_id": "NCT01364649", "title": "Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Treatment Outcome" ], "interventions": [ { "name": "Vortioxetine", "type": "DRUG" }, { "name": "Escitalopram", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 447, "start_date": "2011-06", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2014-10-09", "last_synced_at": "2026-10-09T00:43:47.271Z", "location_count": 53, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Anaheim, California + 50 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Chino", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01364649" }, { "nct_id": "NCT06965569", "title": "Multiple Ascending Dose Phase 1 Study of ALA-3000", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Treatment Resistant Depression" ], "interventions": [ { "name": "ALA-3000", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "escitalopram, sertraline, duloxetine or venlafaxine XR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alar Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 37, "start_date": "2025-04-21", "completion_date": "2025-12-30", "has_results": false, "last_update_posted_date": "2025-12-31", "last_synced_at": "2026-10-09T00:43:47.271Z", "location_count": 4, "location_summary": "Little Rock, Arkansas • St Louis, Missouri • Eatontown, New Jersey + 1 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Eatontown", "state": "New Jersey" }, { "city": "North Canton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06965569" }, { "nct_id": "NCT00590863", "title": "Combining Medications to Enhance Depression Outcomes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "SSRI + placebo", "type": "DRUG" }, { "name": "Escitalopram + Bupropion SR", "type": "DRUG" }, { "name": "Venlafaxine XR + Mirtazapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Mental Health (NIMH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 665, "start_date": "2008-03", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2014-04-23", "last_synced_at": "2026-10-09T00:43:47.271Z", "location_count": 15, "location_summary": "Tuscaloosa, Alabama • Harbor City, California • Los Angeles, California + 12 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Harbor City", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00590863" }, { "nct_id": "NCT01436149", "title": "Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "SPD489 (Lisdexamfetamine dimesylate )", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 1262, "start_date": "2011-10-27", "completion_date": "2013-12-23", "has_results": true, "last_update_posted_date": "2021-06-09", "last_synced_at": "2026-10-09T00:43:47.271Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Carson, California • Irvine, California + 42 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Carson", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Norwalk", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01436149" }, { "nct_id": "NCT00048815", "title": "Drug Therapy to Treat Minor Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression" ], "interventions": [ { "name": "Citalopram", "type": "DRUG" }, { "name": "St. John's Wort", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 73, "start_date": "2003-02", "completion_date": "2007-04", "has_results": true, "last_update_posted_date": "2018-05-11", "last_synced_at": "2026-10-09T00:43:47.271Z", "location_count": 3, "location_summary": "Los Angeles, California • Boston, Massachusetts • Pittsburgh, Pennsylvania", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00048815" }, { "nct_id": "NCT04476030", "title": "A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "SAGE-217", "type": "DRUG" }, { "name": "Matching Placebo", "type": "DRUG" }, { "name": "Sertraline", "type": "DRUG" }, { "name": "Escitalopram", "type": "DRUG" }, { "name": "Citalopram", "type": "DRUG" }, { "name": "Duloxetine", "type": "DRUG" }, { "name": "Desvenlafaxine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 440, "start_date": "2020-11-09", "completion_date": "2021-12-22", "has_results": true, "last_update_posted_date": "2023-12-22", "last_synced_at": "2026-10-09T00:43:47.271Z", "location_count": 51, "location_summary": "Dothan, Alabama • Phoenix, Arizona • Anaheim, California + 42 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04476030" }, { "nct_id": "NCT00666757", "title": "A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Depression" ], "interventions": [ { "name": "duloxetine", "type": "DRUG" }, { "name": "fluoxetine", "type": "DRUG" }, { "name": "citalopram", "type": "DRUG" }, { "name": "paroxetine", "type": "DRUG" }, { "name": "sertraline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 750, "start_date": "2008-05", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2010-06-15", "last_synced_at": "2026-10-09T00:43:47.271Z", "location_count": 61, "location_summary": "Carson, California • Irvine, California • San Diego, California + 58 more", "locations": [ { "city": "Carson", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Sherman Oaks", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00666757" }, { "nct_id": "NCT00854100", "title": "Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Antidepressant + placebo", "type": "DRUG" }, { "name": "Antidepressant + cariprazine (0.1-0.3 mg/day)", "type": "DRUG" }, { "name": "Antidepressant + cariprazine (1-2 mg/d)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 231, "start_date": "2009-06-30", "completion_date": "2010-12-06", "has_results": true, "last_update_posted_date": "2019-03-05", "last_synced_at": "2026-10-09T00:43:47.271Z", "location_count": 41, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Arcadia, California + 35 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Arcadia", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00854100" } ] }